Gyre Therapeutics Inc (GYRE)

Oct 16, 2025

H.C. Wainwright reiterates Buy rating on Gyre Therapeutics stock at $18 - Investing.com

Oct 16, 2025

Oct 15, 2025

GNI's Gyre Therapeutics Completes Enrollment for Phase 3 Pneumoconiosis Drug Trial - MarketScreener

Oct 15, 2025

Oct 15, 2025

What dividend safety score for Gyre Therapeutics Inc. stock2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Will breakout in Gyre Therapeutics Inc. lead to full recoveryJuly 2025 Retail & Weekly Momentum Picks - newser.com

Oct 15, 2025

Oct 15, 2025

What momentum shifts mean for Gyre Therapeutics Inc.Quarterly Market Review & Momentum Based Trading Signals - newser.com

Oct 15, 2025

Oct 15, 2025

Gyre Therapeutics Announces Completion of Patient - GlobeNewswire

Oct 15, 2025

Oct 15, 2025

272 Patients Enrolled — Gyre Therapeutics' Phase 3 Pirfenidone Trial Completes at 18 China Sites - Stock Titan

Oct 15, 2025

Oct 14, 2025

Using Ichimoku Cloud for Gyre Therapeutics Inc. technicalsWeekly Stock Summary & Verified Momentum Stock Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

MarketsMedicine Hat News - FinancialContent

Oct 14, 2025

Oct 14, 2025

High Growth US Tech Stocks To Watch In October 2025 - Yahoo Finance

Oct 14, 2025

Oct 14, 2025

Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD-The Liver Meeting® 2025 - The Manila Times

Oct 14, 2025

Oct 14, 2025

Gyre Therapeutics to Present Positive Phase 3 Trial Results of Hydronidone for Liver Fibrosis at The Liver Meeting® 2025 - Quiver Quantitative

Oct 14, 2025

Oct 14, 2025

Gyre Therapeutics to Present Results from Positive Phase 3 - GlobeNewswire

Oct 14, 2025

Oct 14, 2025

Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025 - Stock Titan

Oct 14, 2025

Oct 14, 2025

How to integrate Gyre Therapeutics Inc. into portfolio analysis toolsJuly 2025 Selloffs & Accurate Technical Buy Alerts - newser.com

Oct 14, 2025

Oct 13, 2025

Using fundamentals and technicals on Gyre Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up – Should You Buy? - Defense World

Oct 13, 2025

Oct 11, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's Why - MarketBeat

Oct 11, 2025

Oct 10, 2025

Gyre Therapeutics Stock Price, Quotes and Forecasts - Benzinga

Oct 10, 2025

Oct 10, 2025

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.com - Investing.com Nigeria

Oct 10, 2025

Oct 10, 2025

Visual trend scoring systems applied to Gyre Therapeutics Inc.2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 10, 2025

Oct 10, 2025

Jefferies Initiates Coverage on Gyre Therapeutics (GYRE) with a "Buy" Rating | GYRE Stock News - GuruFocus

Oct 10, 2025

Oct 10, 2025

Jefferies Initiates Coverage of Gyre Therapeutics (GYRE) with Buy Recommendation - Nasdaq

Oct 10, 2025

Oct 10, 2025

Jefferies Initiates Coverage on Gyre Therapeutics With Buy Rating, $16 Price Target - MarketScreener

Oct 10, 2025

Oct 10, 2025

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target - Investing.com

Oct 10, 2025

Oct 09, 2025

Gyre Therapeutics (NASDAQ:GYRE) Earns Sell (D) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 07, 2025

Gyre Therapeutics Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Small Investment Portfolio - earlytimes.in

Oct 07, 2025

Oct 05, 2025

Can momentum traders help lift Gyre Therapeutics Inc.Weekly Trend Report & Safe Entry Point Identification - newser.com

Oct 05, 2025

Oct 05, 2025

Gyre Therapeutics Inc. stock outlook for YEARJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com

Oct 05, 2025

Oct 05, 2025

Volatility clustering patterns for Gyre Therapeutics Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - newser.com

Oct 05, 2025

Oct 01, 2025

Real time alert setup for Gyre Therapeutics Inc. performanceTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 01, 2025

Sep 30, 2025

Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN

Sep 30, 2025

Sep 30, 2025

Discovering 3 Undiscovered Gems In The US Market - simplywall.st

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Group Inc. Cuts Stock Position in Gyre Therapeutics, Inc. $GYRE - Defense World

Sep 30, 2025

Sep 29, 2025

Developing predictive dashboards with Gyre Therapeutics Inc. dataPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com

Sep 29, 2025